SACS issued a health alert regarding illegal marketing of Alecensa oncology drug (150mg capsules) in Venezuela
Lot B7011B01 (registration E.F. 42.991/22) was identified as illegally imported from India via DHL
The medication was manufactured by F. Hoffmann-La Roche Ltd. for the Chinese market and bears a 'Patient Assistance Program Not for Sale' label
Authorities state there is no guarantee of origin, composition, storage, or effectiveness, creating serious health risks
The claims, made testable
- asserted — check unavailable SACS issued a health alert regarding illegal marketing of Alecensa oncology drug (150mg capsules) in Venezuela (evidence: not measured)
- asserted — check unavailable Lot B7011B01 (registration E.F. 42.991/22) was identified as illegally imported from India via DHL (evidence: not measured)
- asserted — check unavailable The medication was manufactured by F. Hoffmann-La Roche Ltd. for the Chinese market and bears a 'Patient Assistance Program Not for Sale' label (evidence: not measured)
Pattern: 143 related Venezuela signals in the last 30 days on Health regulation, Drug trafficking, Public health safety, Pharmaceutical control.
What would change the assessment
- Concrete observable criterion - verification of lot B7011B01 registration E.F. 42.991/22 in SACS database (within 30 days — SACS official registry, INE-VE pharmaceutical tracking system)
Grounded analysis — deterministic intelligence + AI synthesis anchored to real signals (deterministic only (no LLM synthesis)). No fact is asserted that the sources do not support.
What the sources establish
The source makes the assertions summarized above; VeraVadis has not yet found independent corroboration in its corpus.
Actors named in sources
Servicio Autónomo de Contraloría Sanitaria (SACS) · Instituto Nacional de Higiene Rafael Rangel · Productos Roche, S.A. · F. Hoffmann-La Roche Ltd. · Banco de Drogas Antineoplásicas Badán · Fundación Badán · DHL · India
Click an actor to see other briefs that name it.
What's still unverified
- Everything above is one outlet's account; none of it has been independently corroborated yet.
AI-assisted synthesis anchored to a real VeraVadis-analyzed source. Cleared by VeraVadis's automated editorial gates on 2026-09-16 — not reviewed by a human editor. Archive piece: published under our earlier method. It does not carry the per-claim evidence chain — who reported it first and who is echoing whom — that our current pieces carry. The source link and the date are the original ones.
